Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/09/057915
CTRI/2023/09/057915
Not yet recruiting
Phase 3

Effect of Validated Yoga Protocol in the management of Polycystic ovarian Syndrome - NI

Banaras Hindu University0 sites0 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Status
Not yet recruiting
OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •Patients who satisfied the Rotterdam criterion (2/3 of the features) for PCOS will be included in the study. The following were the
  • •definitions of the three features. Oligo/amenorrhea: Absence of menstruation for 45 days or more and/or less than eight menses per
  • •Clinical hyperandrogenism, Modified Ferriman and
  • •Gallway (mFG) score of 6 or higher. Biochemical hyperandrogenism, serum LH and FSH ratio more than 2:1\.
  • •Poly cystic ovaries: Presence of \>10 cysts, 2\-8 mm in diameter, usually combined with increased ovarian volume of \>10 cm3, and an echo\-dense stroma in pelvic ultrasound scan

Exclusion Criteria

  • •Patients who use of oral contraceptives/hormone
  • •treatment/insulin\-sensitizing agents within
  • •previous six weeks.
  • •Patients who have addiction of alcohol, smoking and any prior experience of yoga.
  • •Patients who have Hyperprolactinemia, thyroid abnormalities and non\-classic adrenal hyperplasia, and those who did not consent for the study.
  • •Patients who have Primary ammenorheoa, Premature ovarian failure, absent ovary and uterus.
  • •The patients suffering from diabetes mellitus, hypertension, thyroid disorders, hyperprolactinemia, congenital adrenal hyperplasia, other gynaecological disorders, and renal failure.
  • •Patients with evidence of malignancy.
  • •Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho\-Neuro\-Endocrinal disorders, etc.)
  • •Patients who have a past history of Atrial Fibrillation, Coronary Artery Disease (CAD), Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.

Investigators

Similar Trials

Not yet recruiting
Phase 2
YOGA PROTOCOL IN PREMENSTRUAL SYNDROMEHealth Condition 1: F063- Mood disorder due to known physiological condition
CTRI/2022/02/039932DR SUMA RAJAPUT
Completed
Not Applicable
Benefits of Yoga Program in the Management of Diabetes
CTRI/2016/08/007172Art Of Living foundation109
Not yet recruiting
Not Applicable
Effect of yoga module for the management of internet gaming among childre
CTRI/2022/06/043063agalakshmi S Rao
Completed
Not Applicable
Evaluating the effect of Yoga in Management of Asthma.
CTRI/2020/02/023534ttarakhand state council for science technologyUCOST200
Not yet recruiting
Phase 1
Yoga for generalised anxiety disorderHealth Condition 1: F411- Generalized anxiety disorder
CTRI/2023/08/056574Mr Ningombam Ganga Singh